Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma.

Strijker M, Soer EC, de Pastena M, Creemers A, Balduzzi A, Beagan JJ, Busch OR, van Delden OM, Halfwerk H, van Hooft JE, van Lienden KP, Marchegiani G, Meijer SL, van Noesel CJ, Reinten RJ, Roos E, Schokker S, Verheij J, van de Vijver MJ, Waasdorp C, Wilmink JW, Ylstra B, Besselink MG, Bijlsma MF, Dijk F, van Laarhoven HW.

Int J Cancer. 2019 Jul 24. doi: 10.1002/ijc.32586. [Epub ahead of print]

PMID:
31340061
2.

Quality of life during palliative systemic therapy for oesophagogastric cancer: systematic review and meta-analysis.

van Kleef JJ, Ter Veer E, van den Boorn HG, Schokker S, Ngai LL, Prins MJ, Mohammad NH, van de Poll-Franse LV, Zwinderman AH, van Oijen MGH, Sprangers MAG, van Laarhoven HWM.

J Natl Cancer Inst. 2019 Jun 28. pii: djz133. doi: 10.1093/jnci/djz133. [Epub ahead of print]

PMID:
31251346
3.

Nasal gene expression changes with inhaled corticosteroid treatment in asthma.

Boudewijn IM, Lan A, Faiz A, Cox CA, Brouwer S, Schokker S, Vroegop SJ, Nawijn MC, Woodruff PG, Christenson SA, Hagedoorn P, Frijlink HW, Choy DF, Brouwer U, Wisman M, Postma DS, Fingleton J, Beasley R, van den Berge M, Guryev V.

Allergy. 2019 Jun 22. doi: 10.1111/all.13952. [Epub ahead of print] No abstract available.

PMID:
31230369
4.

Phase I Dose Escalation Study with Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) as First-Line Treatment of Metastatic Esophagogastric Adenocarcinoma (ACTION Study).

Schokker S, van der Woude SO, van Kleef JJ, van Zoen DJ, van Oijen MGH, Mearadji B, Beenen LFM, Stroes CI, Waasdorp C, Jibodh RA, Creemers A, Meijer SL, Hooijer GKJ, Punt CJA, Bijlsma MF, van Laarhoven HWM.

Cancers (Basel). 2019 Jun 14;11(6). pii: E827. doi: 10.3390/cancers11060827.

5.

Associations of AMP and adenosine induced dyspnea sensation to large and small airways dysfunction in asthma.

Cox CA, Boudewijn IM, Vroegop SJ, Schokker S, Lexmond AJ, Frijlink HW, Hagedoorn P, Vonk JM, Farenhorst MP, Ten Hacken NHT, Kerstjens HAM, van den Berge M.

BMC Pulm Med. 2019 Jan 28;19(1):23. doi: 10.1186/s12890-019-0783-0.

6.

Predictors of clinical response to extrafine and non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.

Gafar F, Boudewijn IM, Cox CA, Vonk JM, Schokker S, Lexmond AJ, Frijlink HW, Hagedoorn P, Postma DS, van den Berge M.

Respir Res. 2018 Dec 18;19(1):256. doi: 10.1186/s12931-018-0961-2.

7.

Prognostic and predictive factors for overall survival in metastatic oesophagogastric cancer: A systematic review and meta-analysis.

Ter Veer E, van Kleef JJ, Schokker S, van der Woude SO, Laarman M, Haj Mohammad N, Sprangers MAG, van Oijen MGH, van Laarhoven HWM.

Eur J Cancer. 2018 Nov;103:214-226. doi: 10.1016/j.ejca.2018.07.132. Epub 2018 Sep 28.

PMID:
30268922
8.

Extrafine compared to non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.

Cox CA, Boudewijn IM, Vroegop SJ, Schokker S, Lexmond AJ, Frijlink HW, Hagedoorn P, Vonk JM, Farenhorst MP, Ten Hacken NHT, Kerstjens HAM, Postma DS, van den Berge M.

Respir Med. 2017 Sep;130:35-42. doi: 10.1016/j.rmed.2017.07.005. Epub 2017 Jul 8.

9.

Bronchial Provocation Testing Can Be Improved by Using Dry Powder Adenosine Instead of Nebulized Adenosine Monophosphate.

Lexmond AJ, Boudewijn IM, Hagedoorn P, Schokker S, Cox CA, Vonk JM, Ten Hacken NHT, Frijlink HW, Vroegop SJ, van den Berge M.

Am J Respir Crit Care Med. 2018 Feb 1;197(3):391-394. doi: 10.1164/rccm.201704-0715LE. No abstract available.

PMID:
28650210
10.

Cerebrovascular, cardiovascular and renal hypertensive disease after hypertensive disorders of pregnancy.

Schokker SA, Van Oostwaard MF, Melman EM, Van Kessel JP, Baharoglu MI, Roos YB, Vogt L, De Winter RJ, Mol BW, Ganzevoort W.

Pregnancy Hypertens. 2015 Oct;5(4):287-93. doi: 10.1016/j.preghy.2015.06.002. Epub 2015 Jun 22.

PMID:
26597742
11.

Survival differences in pediatric pulmonary arterial hypertension: clues to a better understanding of outcome and optimal treatment strategies.

Zijlstra WMH, Douwes JM, Rosenzweig EB, Schokker S, Krishnan U, Roofthooft MTR, Miller-Reed K, Hillege HL, Ivy DD, Berger RMF.

J Am Coll Cardiol. 2014 May 27;63(20):2159-2169. doi: 10.1016/j.jacc.2014.02.575. Epub 2014 Mar 26.

12.

Development of a brief questionnaire (ICQ-S) to monitor inhaled corticosteroid side-effects in clinical practice.

Foster JM, Schokker S, Sanderman R, Postma DS, van der Molen T.

Allergy. 2014 Mar;69(3):372-9. doi: 10.1111/all.12340. Epub 2014 Jan 21.

PMID:
24444382
13.

Primary prevention of chronic obstructive pulmonary disease in primary care.

van der Molen T, Schokker S.

Proc Am Thorac Soc. 2009 Dec;6(8):704-6. doi: 10.1513/pats.200907-062DP. Review.

PMID:
20008880
14.

Prescribing of asthma medication in primary care for children aged under 10.

Schokker S, Groenhof F, van der Veen WJ, van der Molen T.

Prim Care Respir J. 2010 Mar;19(1):28-34. doi: 10.4104/pcrj.2009.00039.

15.

Fluticasone or montelukast for preschool children with asthma-like symptoms: Randomized controlled trial.

Kooi EM, Schokker S, Marike Boezen H, de Vries TW, Vaessen-Verberne AA, van der Molen T, Duiverman EJ.

Pulm Pharmacol Ther. 2008 Oct;21(5):798-804. doi: 10.1016/j.pupt.2008.06.004. Epub 2008 Jul 2.

PMID:
18647656
16.

Inhaled corticosteroids for recurrent respiratory symptoms in preschool children in general practice: randomized controlled trial.

Schokker S, Kooi EM, de Vries TW, Brand PL, Mulder PG, Duiverman EJ, van der Molen T.

Pulm Pharmacol Ther. 2008;21(1):88-97. Epub 2007 Jan 23.

PMID:
17350868
17.

Airway resistance measurements in pre-school children with asthmatic symptoms: the interrupter technique.

Kooi EM, Schokker S, van der Molen T, Duiverman EJ.

Respir Med. 2006 Jun;100(6):955-64. Epub 2006 Feb 28. Review.

18.

Development, validity and responsiveness of the Clinical COPD Questionnaire.

van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF.

Health Qual Life Outcomes. 2003 Apr 28;1:13.

Supplemental Content

Loading ...
Support Center